Diaceutics (DXRX) Insider Trading & Ownership GBX 120.50 -3.50 (-2.82%) (As of 11:06 AM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades Diaceutics (LON:DXRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage34.30%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)£85,047.46Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)£765,000.00 Get DXRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Diaceutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address DXRX Insider Buying and Selling by Quarter Ad Huge AlertsUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Click here to see how this opportunity could transform your portfolio. Diaceutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/30/2024Nick RobertsInsiderBuy112GBX 134£150.088/28/2024Nick RobertsInsiderBuy113GBX 134£151.426/28/2024Nick RobertsInsiderBuy122GBX 1GBX 1225/22/2024Graham PatersonInsiderBuy39,934GBX 129£51,514.863/28/2024Peter KeelingInsiderSell750,000GBX 102£765,0003/6/2024Graham PatersonInsiderBuy33,564GBX 99£33,228.361/30/2024Nick RobertsInsiderBuy152GBX 1GBX 152 (Data available from 1/1/2013 forward) DXRX Insider Trading Activity - Frequently Asked Questions Who is on Diaceutics's Insider Roster? The list of insiders at Diaceutics includes Deborah Davis, Graham Paterson, Nick Roberts, and Peter Keeling. Learn more on insiders at DXRX. What percentage of Diaceutics stock is owned by insiders? 34.30% of Diaceutics stock is owned by insiders. Learn more on DXRX's insider holdings. Which Diaceutics insiders have been buying company stock? The following insiders have purchased DXRX shares in the last 24 months: Graham Paterson (£84,743.22), and Nick Roberts (£20,909.35). How much insider buying is happening at Diaceutics? Insiders have purchased a total of 96,712 DXRX shares in the last 24 months for a total of £105,652.57 bought. Which Diaceutics insiders have been selling company stock? The following insider sold DXRX shares in the last 24 months: Peter Keeling (£765,000). How much insider selling is happening at Diaceutics? Insiders have sold a total of 750,000 Diaceutics shares in the last 24 months for a total of £765,000 sold. Diaceutics Key ExecutivesMr. Ryan Keeling (Age 42)CEO & Director Compensation: $334.27kMr. Peter Keeling (Age 64)Founder & Executive Director Compensation: $363.24kMr. Nicholas Stewart Roberts (Age 42)CFO & Director Compensation: $180.37kMs. Julie BrowneChief Operating OfficerMs. Gillian ShawGeneral CounselMs. Norma ThompsonGlobal Head of Human ResourcesMr. Jordan ClarkChief Commercial OfficerMs. Susanne MunkstedChief Precision Medicine OfficerMs. Jillian BeggsChief Commercial OfficerMs. Marieke HoefsmitSenior Director & Head of Data Delivery Netherlands More Insider Trading Tools from MarketBeat Related Companies Abingdon Health Insider Trading MaxCyte Insider Trading NIOX Group Insider Trading Alliance Pharma Insider Trading Arix Bioscience Insider Trading Bioventix Insider Trading Tristel Insider Trading 4basebio Insider Trading EKF Diagnostics Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (LON:DXRX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Diaceutics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Diaceutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
